Latest News & Updates

Breaking News

  • 10 hours ago

  • Vaibhavi M.

Novo Nordisk Reports REDEFINE 4 Results As CagriSema Shows 23% Weight Loss But Misses Non-Inferiority To Tirzepatide
Breaking News
IDEAYA Biosciences Appoints Dr Theodora Ross, A Former AbbVie Oncology R&D Leader As Chief Development Officer To Advance Precision Oncology Pipeline

Vaibhavi M.

Other trending news you may like to read

Novo Nordisk Reports REDEFINE 4 Results As CagriSema Shows 23% Weight Loss But Misses Non-Inferiority To Tirzepatide

Novo reports REDEFINE 4 data as CagriSema shows 23% weight loss but misses non-inferiority vs tirzepatide.

Vaibhavi M.

Pharma Now

IDEAYA Biosciences Appoints Dr Theodora Ross, A Former AbbVie Oncology R&D Leader As Chief Development Officer To Advance Precision Oncology Pipeline

IDEAYA appoints Dr Theodora Ross as Chief Development Officer to advance its precision oncology pipeline.

Vaibhavi M.

Pharma Now

European Commission Grants Approval To Sandoz’s Ranluspec Ranibizumab Biosimilar For Retinal Diseases, Expands Ophthalmology Portfolio

EU approves Sandoz’s Ranluspec ranibizumab biosimilar for multiple retinal diseases.

Vaibhavi M.

Pharma Now

Merck Restructures Human Health Business, Appoints New Leaders To Drive Oncology And Speciality Growth

Merck restructures Human Health into Oncology and Specialty units, appointing new executive leaders.

Vaibhavi M.

Pharma Now